FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1424-1425 November 8, 2001 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: The study reported by Klempner et al. (July 12 issue)¹ showed that patients with chronic Lyme disease are ill; it also showed that the antibiotics used (intravenous ceftriaxone for one month, followed by oral doxycycline for two months) did not lead to improvement. The study did not answer the question of whether better outcomes would have resulted from a longer duration of either intravenous ceftriaxone or oral doxycycline therapy or from treatment with different antibiotics for the same or a longer period. The assumption that ceftriaxone and doxycycline are equivalent and additive treatments for chronic Lyme disease . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Cairns, V., Godwin, J. (2005). Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol 34: 1340-1345 [Abstract] [Full Text]